Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Tawnya L. Bowles"'
Publikováno v:
JAAD Case Reports, Vol 3, Iss 1, Pp 10-12 (2017)
Externí odkaz:
https://doaj.org/article/0846528c7edc4e07bd8144cd4237977a
Autor:
Tawnya L Bowles, Carol Sweeney, John Snyder, Jesse Gygi, Brad Bott, Daniel Wray, Timothy J Yeatman, William T Sause
Publikováno v:
Melanoma Management, Vol 8, Iss 2 (2021)
Aim: To analyze trends in Utah melanoma diagnosis and study the impact of rurality. Patients & methods: State-wide melanoma incidence was calculated using Surveillance, Epidemiology, and End Results data (2005–2013). A subset of 5199 patients treat
Externí odkaz:
https://doaj.org/article/05eb992c149d43af9fc9d351187db451
Autor:
Elise K. Brunsgaard, Tawnya L. Bowles, Elliot A. Asare, Kenneth Grossmann, Kenneth M. Boucher, Allie Grossmann, Julie A. Jackson, David A. Wada, Richa Rathore, Griffin Budde, Andrew Grandemange, John R. Hyngstrom
Publikováno v:
Melanoma Research. 33:184-191
Autor:
John F. Thompson, John Hyngstrom, Corrado Caracò, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Elisabetta Pennacchioli, Harald J. Hoekstra, Marc Moncrieff, Christian Ingvar, Alexander van Akkooi, Michael S. Sabel, Edward A. Levine, Michael Henderson, Reinhard Dummer, Carlo Riccardo Rossi, John M. Kane, Steven Trocha, Frances Wright, David R. Byrd, Maurice Matter, Alastair MacKenzie-Ross, Mark C. Kelley, Patrick Terheyden, Tara L. Huston, Jeffrey D. Wayne, Heather Neuman, B. Mark Smithers, Darius Desai, Jeffrey E. Gershenwald, Shlomo Schneebaum, Anja Gesierich, Lisa K. Jacobs, James M. Lewis, Cristina O’Donoghue, Armando Sardi, J. Greg McKinnon, Craig L. Slingluff, Jeffrey M. Farma, Erwin Schultz, Randall P. Scheri, Sergi Vidal-Sicart, Alessandro A. E. Testori, Richard A. Scolyer, David E. Elashoff, Alistair J. Cochran, Mark B. Faries
Publikováno v:
Annals of Surgical Oncology.
Autor:
Mohammed Kashani-Sabet, Sancy A. Leachman, Jennifer A. Stein, Jack L. Arbiser, Elizabeth G. Berry, Julide T. Celebi, Clara Curiel-Lewandrowski, Laura K. Ferris, Jane M. Grant-Kels, Douglas Grossman, Rajan P. Kulkarni, Michael A. Marchetti, Kelly C. Nelson, David Polsky, Elizabeth V. Seiverling, Susan M. Swetter, Hensin Tsao, Alexandra Verdieck-Devlaeminck, Maria L. Wei, Anna Bar, Edmund K. Bartlett, Jean L. Bolognia, Tawnya L. Bowles, Kelly B. Cha, Emily Y. Chu, Rebecca I. Hartman, Elena B. Hawryluk, Risa M. Jampel, Lilit Karapetyan, Meenal Kheterpal, David H. Lawson, Philip D. Leming, Tracey N. Liebman, Michael E. Ming, Debjani Sahni, Stephanie A. Savory, Saba S. Shaikh, Arthur J. Sober, Vernon K. Sondak, Natalie Spaccarelli, Richard P. Usatine, Suraj Venna, John M. Kirkwood
Publikováno v:
JAMA Dermatology. 159:545
ImportanceTherapy for advanced melanoma has transformed during the past decade, but early detection and prognostic assessment of cutaneous melanoma (CM) remain paramount goals. Best practices for screening and use of pigmented lesion evaluation tools
Autor:
John R. Hyngstrom, Josh Bleicher, Elliot A. Asare, Shadai Flores, Glen M. Bowen, Tawnya L. Bowles
Publikováno v:
The American Journal of Surgery. 221:844-849
Background Merkel cell carcinoma (MCC) is a rare cutaneous neuroendocrine tumor that primarily affects elderly patients. Despite aggressive treatment, overall survival (OS) remains low. Methods This study is a multi-institutional, retrospective revie
Autor:
Josh Bleicher, Tawnya L. Bowles, Jessica N. Cohan, William Peche, Courtney L. Scaife, T Bartley Pickron, John R. Hyngstrom, Elliot A. Asare, Lyen C. Huang
Publikováno v:
World Journal of Gastroenterology
BACKGROUND Anorectal melanoma (ARM) is a rare disease with a poor prognosis. Evidence on optimal treatment is limited and surgical management varies widely. We hypothesized that the frequency of abdominoperineal resection used as primary treatment of
Autor:
Lauren McGuire, Josh Bleicher, Maranda K Pahlkotter, Tawnya L. Bowles, Douglas S. Swords, Meghan E Mali, John R. Hyngstrom, Elliot A. Asare
Publikováno v:
Journal of Surgical Oncology. 122:1770-1777
Background and objectives The relatively recent availability of effective systemic therapies for metastatic melanoma necessitates reconsideration of current surveillance patterns. Evidence supporting surveillance guidelines for resected Stage II mela
Autor:
Sophie Dalac-Rat, Anna Olsson-Brown, Jiaxin Niu, Praveen K. Bommareddy, Francesca Aroldi, Katy K. Tsai, Terence Duane Rhodes, Robert S. Coffin, Katharina C. Kähler, Adel Samson, Tawnya L. Bowles, Mohammed M. Milhem, Gino K. In, Bartosz Chmielowski, Eva Muñoz, Georgia M. Beasley, Joseph J. Sacco, Scott Baum, Kevin J. Harrington, Mark R. Middleton, Lavita Menezes, Hamid Emamekhoo, Jason Chesney, Andrea Pirzkall, Ari M. Vanderwalde
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundRP1 is an enhanced potency oncolytic HSV-1 which expresses a fusogenic glycoprotein (GALV-GP R-) and granulocyte macrophage colony stimulating factor (GM-CSF).1 In pre-clinical studies, RP1 demonstrated potent GALV-GP R-enhanced anti-tumor
Autor:
Carol Sweeney, John Snyder, Brad Bott, William T. Sause, Timothy J. Yeatman, Jesse Gygi, Daniel Wray, Tawnya L. Bowles
Publikováno v:
Melanoma Management
Aim: To analyze trends in Utah melanoma diagnosis and study the impact of rurality. Patients & methods: State-wide melanoma incidence was calculated using Surveillance, Epidemiology, and End Results data (2005–2013). A subset of 5199 patients treat